Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.53 USD | +3.01% | +13.54% | +24.74% |
Business Summary
Number of employees: 305
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life-changing Medicines
100.0
%
| 0 | nan % | 5 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 5 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Saqib Islam
CEO | Chief Executive Officer | 54 | 17-07-31 |
Daniel Lynch
CHM | Chairman | 65 | 15-12-31 |
Frank Perier
DFI | Director of Finance/CFO | 64 | 19-07-31 |
Tai-An Lin
CTO | Chief Tech/Sci/R&D Officer | 61 | 23-09-10 |
James Cassidy
CTO | Chief Tech/Sci/R&D Officer | 65 | 21-07-31 |
Badreddin Edris
COO | Chief Operating Officer | 37 | 18-08-31 |
Kim Diamond
IRC | Investor Relations Contact | - | 18-07-31 |
Bhavesh Ashar
PRN | Corporate Officer/Principal | 58 | 21-03-21 |
Daniel Pichl
HRO | Human Resources Officer | 41 | 20-07-31 |
Michael Nofi
AUD | Comptroller/Controller/Auditor | 53 | 19-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Fuhrman
BRD | Director/Board Member | 67 | 19-07-31 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 17-07-31 |
Carlos Alban
BRD | Director/Board Member | 61 | 22-07-13 |
Daniel Lynch
CHM | Chairman | 65 | 15-12-31 |
Saqib Islam
CEO | Chief Executive Officer | 54 | 17-07-31 |
Julie Hambleton
BRD | Director/Board Member | 66 | 20-05-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,193,558 | 70,439,695 ( 94.94 %) | 133,662 ( 0.1802 %) | 94.94 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.74% | 3.35B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SWTX Stock
- Company SpringWorks Therapeutics, Inc.